Cargando…
Promoter methylation analysis of CDH1 and p14ARF genes in patients with urothelial bladder cancer
BACKGROUND/AIM: Urothelial bladder cancer arises from the accumulation of multiple epigenetic and genetic changes. We aimed to investigate the specificity and sensitivity of gene-specific promoter methylation of CDH1 and p14ARF genes in the early diagnosis of bladder cancer and compare those with ot...
Autores principales: | Bayramov, Bayram, Gunes, Sezgin, Buyukalpelli, Recep, Aydın, Oğuz, Henkel, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056157/ https://www.ncbi.nlm.nih.gov/pubmed/30050310 http://dx.doi.org/10.2147/OTT.S158259 |
Ejemplares similares
-
Glutamate transporter SLC1A1 is associated with clear cell renal cell carcinoma
por: ERGÜN, Sercan, et al.
Publicado: (2019) -
The role of ketotifen in the prevention of testicular damage in rats with experimental unilateral undescended testes
por: Acikgoz, Abdullah, et al.
Publicado: (2014) -
Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis
por: Chen, Feng, et al.
Publicado: (2016) -
P14(ARF): The Absence that Makes the Difference
por: Cilluffo, Danilo, et al.
Publicado: (2020) -
Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma
por: Xiaofang, Liu, et al.
Publicado: (2012)